Severe Contrast-Induced Nephropathy Leading to Dialysis Occurring in a Patient with Near-Normal Baseline Creatinine Undergoing CT Angiography Using Intravenous Contrast Only

Mohammad Reza Movahed

doi:10.1055/s-0041-1741471

International Journal of Angiology, Inhaltsverzeichnis

Int J Angiol 2023; 32(04): 277-279
DOI: 10.1055/s-0041-1741471

Case Report

Severe Contrast-Induced Nephropathy Leading to Dialysis Occurring in a Patient with Near-Normal Baseline Creatinine Undergoing CT Angiography Using Intravenous Contrast Only

Autoren

Mohammad Reza Movahed

¹Department of Medicine, University of Arizona, Phoenix, Arizona

²Department of Medicine, University of Arizona Sarver Heart Center, Tucson, Arizona

Abstract

Contrast-induced nephropathy can be a major health issue in patients undergoing iodinated contrast exposure. Recently a published paper misleadingly suggested that intravenous administration of iodinated contrast is not a significant cause of contrast-induced nephropathy. This contrasts with previous studies and clinical observations of numerous contrast-induced nephropathy cases occurring in the setting of intravenous contrast exposure. A severe cause of contrast-induced nephropathy is presented occurring in a patient with near-normal creatinine receiving intravenous contrast only leading to dialysis and near death.

Keywords

contrast-induced nephropathy - contrast media - dialysis - intravenous contrast - coronary angiography - intra-arterial contrast exposure

Volltext

Referenzen

References
1 Katzberg RW, Haller C. Contrast-induced nephrotoxicity: clinical landscape. Kidney Int Suppl 2006; (100) S3-S7
2 Gami AS, Garovic VD. Contrast nephropathy after coronary angiography. Mayo Clin Proc 2004; 79 (02) 211-219
3 Gurm HS, Dixon SR, Smith DE. et al; BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) Registry. Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2011; 58 (09) 907-914
4 Luk L, Steinman J, Newhouse JH. Intravenous contrast-induced nephropathy-the rise and fall of a threatening idea. Adv Chronic Kidney Dis 2017; 24 (03) 169-175
5 Einstein AJ, Newhouse JH. Differences in nephrotoxicity between modes of iodinated contrast material administration in patients suspected of having coronary artery disease. Radiology 2019; 292 (03) 673-675
6 Hinson JS, Ehmann MR, Fine DM. et al. Risk of acute kidney injury after intravenous contrast media administration. Ann Emerg Med 2017; 69 (05) 577-586.e4
7 McDonald RJ, McDonald JS, Carter RE. et al. Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality. Radiology 2014; 273 (03) 714-725
8 Katzberg RW, Newhouse JH. Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe?. Radiology 2010; 256 (01) 21-28
9 Rudnick MR, Leonberg-Yoo AK, Litt HI, Cohen RM, Hilton S, Reese PP. The controversy of contrast-induced nephropathy with intravenous contrast: what is the risk?. Am J Kidney Dis 2020; 75 (01) 105-113
10 Nyman U, Almén T, Jacobsson B, Aspelin P. Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections?. Eur Radiol 2012; 22 (06) 1366-1371
11 Polena S, Yang S, Alam R. et al. Nephropathy in critically Ill patients without preexisting renal disease. Proc West Pharmacol Soc 2005; 48: 134-135
12 Lakhal K, Ehrmann S, Chaari A. et al. Acute kidney injury network definition of contrast-induced nephropathy in the critically ill: incidence and outcome. J Crit Care 2011; 26 (06) 593-599
13 Nguyen SA, Suranyi P, Ravenel JG. et al. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function. Radiology 2008; 248 (01) 97-105
14 Mitchell AM, Jones AE, Tumlin JA, Kline JA. Incidence of contrast-induced nephropathy after contrast-enhanced computed tomography in the outpatient setting. Clin J Am Soc Nephrol 2010; 5 (01) 4-9
15 Stacul F, van der Molen AJ, Reimer P. et al; Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 2011; 21 (12) 2527-2541
16 Kakkar R, Sobieszczyk P, Binkert CA, Faxon DP, Mortele KJ, Singh AK. Prevention of intravenous contrast-induced nephropathy in hospital inpatients. Crit Pathw Cardiol 2008; 7 (01) 1-4
17 Kane GC, Doyle BJ, Lerman A, Barsness GW, Best PJ, Rihal CS. Ultra-low contrast volumes reduce rates of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography. J Am Coll Cardiol 2008; 51 (01) 89-90
18 Taliercio CP, Vlietstra RE, Fisher LD, Burnett JC. Risks for renal dysfunction with cardiac angiography. Ann Intern Med 1986; 104 (04) 501-504
19 Karlsberg RP, Dohad SY, Sheng R. Iodixanol Peripheral Computed Tomographic Angiography Study Investigator Panel. Contrast medium-induced acute kidney injury: comparison of intravenous and intraarterial administration of iodinated contrast medium. J Vasc Interv Radiol 2011; 22 (08) 1159-1165
20 Chaudhury P, Armanyous S, Harb SC. et al. Intra-arterial versus intravenous contrast and renal injury in chronic kidney disease: a propensity-matched analysis. Nephron 2019; 141 (01) 31-40
21 Kooiman J, Le Haen PA, Gezgin G. et al. Contrast-induced acute kidney injury and clinical outcomes after intra-arterial and intravenous contrast administration: risk comparison adjusted for patient characteristics by design. Am Heart J 2013; 165 (05) 793-799 , 799.e1